India Pesticides, KIMS get Sebi s go-ahead to launch IPOs
SECTIONS
Last Updated: May 03, 2021, 07:13 PM IST
Share
Synopsis
The two companies filed their preliminary papers with the Securities and Exchange Board of India (Sebi) in February.
Sebi s observation is necessary for any company to launch public issues like initial public offer (IPO), follow-on public offer (FPO)and rights issue.
Related
NEW DELHI: Agrochemical technicals firm India Pesticides and the Krishna Institute of Medical Sciences have received capital markets regulator Sebi s go-ahead to float initial share-sales.
Krishna Institute of Medical Sciences (KIMS) and India Pesticides obtained Sebi s observation on April 28 and April 30, respectively, an update with Sebi showed on Monday.
IFLR Asia-Pacific Awards 2021: winners announced iflr.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from iflr.com Daily Mail and Mail on Sunday newspapers.
Explore Now
Nifty futures on the Singapore Exchange traded 4 points, or 0.03 per cent, lower at 15,415 in signs that Dalal Street was headed for a tepid start on Friday. Here are a few stocks which may buzz the most in today s trade:
SBI: State Bank of India (
SBI) will conduct e-auctions of 12 bad accounts this month to recover dues of over Rs 506 crore under sale to asset reconstruction company (ARC) mechanism.
Housing: At least two existing overseas investors in PNB Housing Finance – the Carlyle Group and General Atlantic Singapore – are believed to have hired consultants to carry out a due diligence on the mortgage lender, which is looking to tap these investors for equity expansion.
Hutchison China MediTech Limited Reports 2020 Full Year Results and Provides Business Updates apnews.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from apnews.com Daily Mail and Mail on Sunday newspapers.
URL copied
Krishna Institute of Medical Sciences files Rs 700-crore IPO papers
Krishna Institute of Medical Sciences Ltd has filed preliminary papers with capital markets regulator Sebi to raise Rs 700 crore through an initial share-sale. The initial public offering (IPO) comprises a fresh issue of shares aggregating up to Rs 200 crore and an offer for sale of up to 21,340,931 equity shares from promoters and existing shareholders, according to draft red herring prospectus filed with Sebi.
A total of 1,39,77,991 equity shares would be offered by General Atlantic Singapore KH Pte Ltd under the offer for sale, up to 7,75,933 equity shares by Bhaskara Rao Bollineni, up to 11,63,899 equity shares by Rajyasri Bollineni, up to 3,87,966 equity shares by Bollineni Ramanaiah Memorial Hospitals Pvt Ltd.